Andy Chan
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
-
- Phagocytosis and Immune Regulation
Papers in
-
- Protein Degradation and Inhibitors 1
-
- Cancer Genomics and Diagnostics 1
- Co-authors
- Erinn B. Rankin (4 shared papers)David Lindgren (1 shared paper)Adam J. Krieg (1 shared paper)Edward L. LaGory (1 shared paper)Håkan Axelson (1 shared paper)Mihalis S. Kariolis (1 shared paper)Yu Rebecca Miao (1 shared paper)Anh N. Diep (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (1 paper)Cancer Biology & Therapy (1 paper)Oncotarget (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesNetherlandsChina
In The Last Decade
Andy Chan
4 papers receiving 318 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 89
- Immunology 109
- Oncology 110
- Pulmonary and Respiratory Medicine 82
- Molecular Biology 147
Countries citing papers authored by Andy Chan
This map shows the geographic impact of Andy Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Chan more than expected).
Fields of papers citing papers by Andy Chan
This network shows the impact of papers produced by Andy Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Chan. The network helps show where Andy Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Andy Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 221 | |
| 2 | 2017 | 72 | |
| 3 | 2016 | 25 | |
| 4 | 2020 | 3 | |
| 5 | 2018 | 0 |
About Andy Chan
Andy Chan is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 5 papers that have together received 321 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Computational Drug Discovery Methods (1 paper), Renal cell carcinoma treatment (1 paper), Cancer Genomics and Diagnostics (1 paper), Protein Degradation and Inhibitors (1 paper), COVID-19 and healthcare impacts (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Cancer Research (89 citations), Immunology (109 citations), Oncology (110 citations), Pulmonary and Respiratory Medicine (82 citations) and Molecular Biology (147 citations). Andy Chan has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include Erinn B. Rankin, David Lindgren, Adam J. Krieg, Edward L. LaGory, Håkan Axelson, Mihalis S. Kariolis, Yu Rebecca Miao, Anh N. Diep, Amato J. Giaccia and Katherine C. Fuh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology, Cancer Biology & Therapy, Oncotarget and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.